Medicinal Chemistry 401: Immunizing Agents 2007
1 / 27

Medicinal Chemistry 401: Immunizing Agents 2007 Instructor: Valerie Daggett, daggett@u.washington - PowerPoint PPT Presentation

  • Uploaded on

Medicinal Chemistry 401: Immunizing Agents 2007 Instructor: Valerie Daggett, Download and learn Childhood immunization schedule.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Medicinal Chemistry 401: Immunizing Agents 2007 Instructor: Valerie Daggett, daggett@u.washington' - Donna

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg

Medicinal Chemistry 401: Immunizing Agents 2007

Instructor: Valerie Daggett,

Download and learn Childhood immunization schedule

The slide sets associated with the topics will be the basis for the lectures. Extra slides may be added and presented in lecture. You should print the slides before class and bring them to lecture.


Childhood Immunization Schedule

CDC Pink Book

Why teach about immunizing agents in pharmacy l.jpg
Why Teach about immunizing agents in Pharmacy?

  • Important health care issue

  • Pharmacists can play a role with education

    • Efficacy

    • Vaccine controversies

    • Changing recommendations

    • Misinformation

    • Patient compliance

    • New vaccines

Why immunize l.jpg
Why immunize?

  • It is effective

    • The widespread use of vaccines has reduced the peak-level of incidence in the US by ≥95%

    • Immunizing also indirectly protects other people such as infants or those with contraindications

  • It saves lives

    • Ex. Measles

    • Before 1963 there were >500,000 cases/yr and

      400-500 deaths/yr

      Now, ~85 cases/yr

Slide4 l.jpg

Disease Pre-vaccine Era* 2005 % change

Diphtheria 31,054 0 -100

Measles 390,852 66 -99

Mumps 21,342 314 -99

Pertussis 117,998 25,616 -78

Polio (wild) 4,953 0 -100

Rubella 9,941 11 -99

Cong. Rubella Synd. 19,177 1 -99

Tetanus 1,314 27 -98

Invasive Hib Disease** 24,856 144 -99

Total 566,706 26,179 -95

Vaccine Adverse Events 0 15,803 +++

Comparison of Maximum and Current Reported Morbidity, Vaccine-Preventable Diseases andVaccine Adverse Events, United States

* Maximum cases reported in pre-vaccine era

** Invasive type b and unknown serotype

Why immunize5 l.jpg
Why immunize?

  • Diseases still with us

    Measles outbreak in 1989-1991

    there were >55,000 cases and 132 deaths

  • It saves money

    • Measles outbreak -> 44,000 days of hospitalization

    • $3-4 million in direct medical treatment costs per 1000 cases

    • $3000-$4000/person

  • You may be administering vaccines

  • Vaccines are different l.jpg
    Vaccines are different

    • Compounds are not drugs until they are approved by a regulatory agency

    • Vaccines have a low rate of market entrance

    • It is expensive and difficult to get them to market

    Vaccines are different7 l.jpg
    Vaccines are different

    • Why?

      • Drugs go to a small number of sick people

      • Vaccines are administered to millions of healthy people

        Higher safety expectations

        Fear of lawsuits

    National childhood vaccine injury act l.jpg
    National Childhood Vaccine Injury Act

    • Passed in 1986

    • Goal: Protect manufacturers of vaccines

    • No-fault alternative to the tort system for resolving claims resulting from adverse reactions to particular vaccines

    • Assumed that vaccine is responsible, which is very hard to prove in court

    Slide9 l.jpg

    Slide10 l.jpg

    • Frist Bill

      • Reform to vaccine injury compensation program

      • Law to apply to individual components…mercury

      • Later, new provisions to protect health care workers with respect to smallpox vaccine administration

    For act l.jpg
    $ for act

    • Excise tax

      $0.75 - $3.00 per vaccine

      All childhood vaccines carry this tax

      Fund paid out ~$50,000,000 in 1998

      $116,000,000 was taken in that year

    Other legal issues l.jpg
    Other legal issues:

    • There have been many lawsuits filed against physicians and hospitals for failure to immunize

    • All were due to ignorance usually involving either new vaccines or new guidelines

    Examples l.jpg

    • Hepatitis B carrier gives birth

      after delivery baby did not get HBIG nor HepB vaccine. Infant became a chronic carrier

    • Hib. Child developed Hib disease which led to brain damage. Parents had tried to get the vaccine but told no because the doctor didn’t know about it.

    Missed opportunity l.jpg
    Missed Opportunity

    A healthcare encounter in which a person is eligible to receive vaccination but is not vaccinated completely

    Reasons for missed opportunities l.jpg
    Reasons for Missed Opportunities

    • Lack of simultaneous administration

    • Unaware child needs additional vaccines

    • Invalid contraindications

    • Inappropriate clinic policies

    • Reimbursement deficiencies

    Reduction to barriers to immunization l.jpg
    Reduction to Barriers to Immunization

    • Physical barriers

      • waiting time

      • distance

    • Psychological barriers

      • unpleasant experience

      • safety concerns

      • misinformation

    Importance of vaccine safety l.jpg
    Importance of Vaccine Safety

    • Decreases in disease risks and increased attention on vaccine risks

    • Public confidence in vaccine safety is critical

      • higher standard of safety is expected of vaccines

      • vaccinees generally healthy (vs. ill for drugs)

      • lower risk tolerance = need to search for rare reactions

      • vaccination universally recommended and mandated

    Importance of vaccine safety18 l.jpg
    Importance of Vaccine Safety

    • Ongoing safety monitoring needed for the development of sound policies and recommendations

    Prelicensure vaccine safety studies l.jpg
    Prelicensure Vaccine Safety Studies

    • Laboratory

    • Animals

    • Humans

    Prelicensure human studies l.jpg
    Prelicensure Human Studies

    • Phases I, II, III trials

    • Common reactions are identified

    • Vaccines are tested in thousands of persons before being licensed and allowed on the market

    Postlicensure surveillance l.jpg
    Postlicensure Surveillance

    • Identify rare reactions

    • Monitor increases in known reactions

    • Identify risk factors for reactions

    • Identify vaccine lots with unusual rates or types of events

    • Identify signals

    Postlicensure vaccine safety activities l.jpg
    Postlicensure Vaccine Safety Activities

    • Phase IV Trials

      • ~10,000 participants

      • better but still limited

    • Large-Linked Databases

    • Clinical Immunization Safety Assessment Network

    Vaccine adverse event reporting system vaers l.jpg
    Vaccine Adverse Event Reporting System (VAERS)

    • National reporting system

    • Jointly administered by CDC and FDA

    • Passive (depends on healthcare providers and others to report)

    • Receives ~15,000 reports per year

    Vaccine safety datalink vsd l.jpg
    Vaccine Safety Datalink (VSD)

    • Large-linked database

    • Links vaccination and health records

    • “Active surveillance”

      • 8 HMOs

      • ~2% of the U.S. population

    • Powerful tool for monitoring vaccine safety

    The provider s role l.jpg
    The Provider’s Role

    • Immunization providers can help to ensure the safety and efficacy of vaccines through proper:

      • vaccine storage and administration

      • timing and spacing of vaccine doses

      • observation of contraindications and precautions

    The provider s role26 l.jpg
    The Provider’s Role

    • Immunization providers can help to ensure the safety and efficacy of vaccines through proper:

      • management of vaccine side effects

      • reporting of suspected side effects to VAERS

      • vaccine benefit and risk communication

    Benefit and risk communication l.jpg
    Benefit and Risk Communication

    • Opportunities for questions should be provided before each vaccination

    • Vaccine Information Statements (VISs)

      • must be provided before each dose of vaccine

      • public and private providers

      • available in multiple languages